Of clinical relevance, we demonstrate that Plin2 expression in different tumor cells confers susceptibility to Trip13‐depletion‐induced mitotic cell death and, importantly, to paclitaxel treatment, the latter representing a mitotic‐spindle‐interfering chemotherapeutic drug commonly used against different cancers. The gene discussed is TRIP13; the disease is neoplasm.